Recent News

• 05.14.2025 - Virtual Annual Shareholder Meeting
• 04.10.2025 - Anthony Petrone
• 04.07.2025 - MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
• 04.07.2025 - MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Leerink's Global Biopharma Conference 2025
• 03.11.2025 - Leerink's Global Biopharma Conference 2025
• 03.10.2025 - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
• 03.10.2025 - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
• 02.26.2025 - MannKind Corporation Fourth Quarter 2024 Earnings Call

Recent Filings

• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.01.2025 - DEF 14A Other definitive proxy statements
• 04.01.2025 - ARS Annual Report to Security Holders
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 4/A Statement of changes in beneficial ownership of securities
• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]